• Serve as strategic advisor & support Lumanity teams in delivery to US-based clients of: Early value strategy & HEOR services (for phase 2 and earlier pipeline assets) • Global value demonstration projects • US-payer launch readiness activities • Translation of value evidence via communications including US value/AMCP formulary dossiers, global value dossiers, proactive payer-facing decks and tools • US economic models including budget impact and cost effectiveness • US HTA strategy, engagement, and technical submissions including ICER, BCBSA Evidence Street, and regional/local payer HTA requirements • Post-approval product differentiation strategies and HEOR services • Leverage US life sciences, pharmacy, and managed care networks in yield of new client relationships, request for proposals, and partnerships • Support development of client proposals • Maintain and expand Lumanity as market-leading technical experts and strategic advisors via participation in relevant HEOR committees & meetings (e.g., ISPOR, AMCP) and participate as co-author in potential Lumanity white papers • Develop strategic networks and partnerships in support of advancing Lumanity service offerings, innovation, and leadership